Epidemiology of Tibial Plateau Fractures in a Tertiary Care Center: A Retrospective Cross Section… (NCT07081165) | Clinical Trial Compass
CompletedNot Applicable
Epidemiology of Tibial Plateau Fractures in a Tertiary Care Center: A Retrospective Cross Sectional Study
137 participantsStarted 2015-07-01
Plain-language summary
A retrospective cross-sectional study was conducted following approval from the institutional review board. Patients who presented to our center over a four-year period, from July 1 2015 to June 30 2019, were included in the study. Participants were selected based on the inclusion and exclusion criteria following review of the medical records. A standardized proforma was used to collect the data and stored in Microsoft Excel. Data processing and analysis was done in Statistical Packages for the Social Sciences (SPSS) version 23.0. All categorical data were presented as percentages along with absolute numbers, while all continuous numerical data were reported as mean ± standard deviation. Tibial plateau fractures were classified according to Schatzker classification, which comprise six types, with severity increasing progressively from type I to type VI.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The study included patients presenting to hospital with diagnosis of tibial plateau fracture, regardless of age, sex, associated injuries and comorbidities. The diagnosis of tibial plateau fracture was confirmed after assessment of X-ray or Computed Tomography (CT) scan by an orthopedic surgeon.
Exclusion Criteria:
* The study excluded patients who presented with a tibia fracture other than a tibial plateau fracture, including proximal tibia fractures and isolated tibial spine fractures. Those with missing records (data or imaging) were excluded from the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.